吉利德药物Remdesivir在冠状病毒患者中产生了快速的康复效果，股票大涨

新闻

🔗

admin 2020-4-17 10:51:09 | 只看该作者 |倒序浏览

本楼：

👍 0

👎

全局：

11179 1206

注册一亩三分地论坛，查看更多干货！

您需要登录才可以下载或查看附件。没有帐号？注册账号

x

指尖新闻：高信噪比，一目了然

https://redian.news/

报道时间:2020-04-17T02:48:00.000Z 新闻链接

Gilead’s two Phase 3 clinical trials were conducted on 125 people recruited by the University of Chicago Medicine. 113 people had severe disease. All the patients have been treated with daily infusions of remdesivir. Kathleen Mullane, the University of Chicago infectious disease specialist overseeing the remdesivir studies for the hospital, said: “Most of our patients are severe and most of them are leaving at six days, so that tells us duration of therapy doesn’t have to be 10 days. We have very few that went out to 10 days, maybe three.” Gilead stock poped 16% in after-hour trading.

新冠疫情追踪